Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin vs Rosuvastatin in Type 2 Diabetes with Dyslipidemia
NCT03784703Phase 4Completed
- Sponsor
- Damanhour University
- Start
- Jan 2018
- Primary completion
- Jan 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of atorvastatin, rosuvastatin in dyslipidemia, sponsored by Damanhour University. Started Jan 2018; status: completed.
02
Drugs
atorvastatinrosuvastatin
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT03784703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03784703.